Smriti Choudhary, M.D
In a study of 1,961 patients assigned to take either semaglutide or placebo for 68 weeks, 86.4% of the patients on semaglutide achieved at least 5% weight loss
doi: 10.1111/pcn.12175 54 ChenKTWuCHTsaiMHWuYCJouMJHuangCCet al
Epithalon and Mitochondrial Health: Power your Healthspan & Lifespan at the Cellular Level Mitochondria are the cellular power plants , responsible for producing ATP, the most common form of energy currency required by all life as we know it, thus far
These data help to explain why an excess of methionine does not lead to a higher elevation of homocysteine in patients with an alteration of the remethylation pathway (caused by folate or cobalamin deficiency and/or by a partial congenital MTHFR defect)
As PTDM and chronic kidney disease are prevalent comorbidities in liver transplant patients, and with the increasing trend of obesity, it is crucial to further investigate and understand the potential benefits and challenges of utilizing GLP-1 RAs and SGLT-2 inhibitors in this population